These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34894999)

  • 21. Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD).
    IsHak WW; Pan D; Steiner AJ; Feldman E; Mann A; Mirocha J; Danovitch I; Melmed GY
    Inflamm Bowel Dis; 2017 May; 23(5):798-803. PubMed ID: 28301432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychological Effects and Medication Adherence among Korean Patients with Inflammatory Bowel Disease during the Coronavirus Disease 2019 Pandemic: A Single-Center Survey.
    Ryu JE; Kang SG; Jung SH; Lee SH; Kang SB
    J Clin Med; 2022 May; 11(11):. PubMed ID: 35683421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic.
    Goodsall TM; Han S; Bryant RV
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1550-1555. PubMed ID: 33063927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of restrictions on psychological outcomes in patients with inflammatory bowel disease on biological treatment during the coronavirus pandemic in Norway.
    Opheim R; Moum KM; Småstuen MC; Moum B
    Qual Life Res; 2023 Mar; 32(3):691-699. PubMed ID: 36125603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Symptoms and Medications of Patients with Inflammatory Bowel Disease in Hubei Province after COVID-19 Epidemic.
    Wang H; Tu L; Li Y; Bai T; Zou K; Xiao F; Li J; Chen M; Zhang H; Li G; Lu Y; Wang K; Jin S; Yang Y; Zhu L; Hou X
    J Immunol Res; 2020; 2020():2847316. PubMed ID: 33062719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of the COVID-19 pandemic on the mental health of patients diagnosed with inflammatory bowel diseases.
    Sarb OF; Vacaras V; Filip VP; Sarb AD; Zaharie RD; Draghici N; Muresanu DF; Tantau AI
    J Med Life; 2023 Dec; 16(12):1864-1868. PubMed ID: 38585531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of the COVID-19 Pandemic on Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey.
    Peyrin-Biroulet L; Ylänne K; Sipes A; Segovia M; Gardiner S; Cappelleri JC; Mulvey A; Panaccione R
    Adv Ther; 2024 Feb; 41(2):598-617. PubMed ID: 38048018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study.
    Al-Hashel JY; Ismail II
    J Headache Pain; 2020 Sep; 21(1):115. PubMed ID: 32972360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis.
    Barberio B; Zamani M; Black CJ; Savarino EV; Ford AC
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):359-370. PubMed ID: 33721557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic.
    Shi L; Lu ZA; Que JY; Huang XL; Liu L; Ran MS; Gong YM; Yuan K; Yan W; Sun YK; Shi J; Bao YP; Lu L
    JAMA Netw Open; 2020 Jul; 3(7):e2014053. PubMed ID: 32609353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of, and outcomes for, inflammatory bowel disease services during the Covid-19 pandemic: a nationwide observational study.
    Deputy M; Sahnan K; Worley G; Patel K; Balinskaite V; Bottle A; Aylin P; Burns EM; Hart A; Faiz O
    Aliment Pharmacol Ther; 2022 Apr; 55(7):836-846. PubMed ID: 35132663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients.
    Azzam NA; Aljebreen A; Almuhareb A; Almadi MA
    Saudi J Gastroenterol; 2020; 26(5):256-262. PubMed ID: 32415045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PedsQL gastrointestinal symptoms scales and gastrointestinal worry scales in pediatric patients with inflammatory bowel disease in comparison with healthy controls.
    Varni JW; Franciosi JP; Shulman RJ; Saeed S; Nurko S; Neigut DA; Bendo CB; Patel AS; Self MM; Saps M; Zacur GM; Denham J; Dark CV; Pohl JF;
    Inflamm Bowel Dis; 2015 May; 21(5):1115-24. PubMed ID: 25793327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Emotional disorders and inflammatory bowel disease].
    Ben Thabet J; Charfi N; Mnif L; Yaich S; Zouari L; Zouari N; Tahri N; Damak J; Maalej M
    Tunis Med; 2012 Jul; 90(7):557-63. PubMed ID: 22811232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors Influencing Anxiety Among WeChat Users During the Early Stages of the COVID-19 Pandemic in Mainland China: Cross-sectional Survey Study.
    Zou C; Zhang W; Sznajder K; Yang F; Jia Y; Ma R; Cui C; Yang X
    J Med Internet Res; 2021 May; 23(5):e24412. PubMed ID: 33878025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.
    Paulides E; Pasma A; Erler NS; van Eijk RLA; de Vries AC; van der Woude CJ
    Dig Dis Sci; 2022 Jul; 67(7):2849-2856. PubMed ID: 34181168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives.
    Sheehan JL; Greene-Higgs L; Swanson L; Higgins PDR; Krein SL; Waljee AK; Saini SD; Berinstein JA; Mellinger JL; Piette JD; Resnicow K; Cohen-Mekelburg S
    Clin Transl Gastroenterol; 2023 Jun; 14(6):e00577. PubMed ID: 36881812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanding telehealth options during the COVID pandemic eliminated racial and age disparities in electronic communication by inflammatory bowel disease patients.
    Hayrapetian L; Zepp M; Rao S; Hennessey M; Houle M; Atienza M; Belfaqeeh OA; Dharia I; Khan A; Borum ML
    J Natl Med Assoc; 2021 Aug; 113(4):474-477. PubMed ID: 33941370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of COVID-19 on the mental health of dialysis patients.
    Bonenkamp AA; Druiventak TA; van Eck van der Sluijs A; van Ittersum FJ; van Jaarsveld BC; Abrahams AC;
    J Nephrol; 2021 Apr; 34(2):337-344. PubMed ID: 33742413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.